Testosterone

testosterone
Androgen AbbVie FDA Monitored

Safety Profile Overview

Androgen replacement for hypogonadism. FDA required cardiovascular risk labeling update in 2015. Monitored for polycythemia and liver toxicity.

Generic Name
testosterone
Brand Names
AndroGel, Testopel, Depo-Testosterone
Therapeutic Class
Androgen
Manufacturer
AbbVie

What Pharma Signal Tracks for Testosterone

Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.

Get Testosterone Safety Data via API

One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Testosterone.

curl "https://api.pharma-signal.com/drug/safety/testosterone" \
  -H "X-API-Key: your_key"

# Returns risk score, adverse event counts,
# serious/death rates, recalls, and signals

Related Safety Intelligence

Pharma Signal provides comparative analysis across therapeutic classes. Compare Testosterone against other Androgen drugs, or explore the full manufacturer portfolio for AbbVie.